Join TESS in Raising Awareness

Learn more!

TAYSHA GENE THERAPIES
RECEIVES RARE PEDIATRIC DISEASE
AND ORPHAN DRUG DESIGNATIONS
FOR SLC13A5 DEFICIENCY

Read Here

Newly diagnosed?

Join our registry!

TESS Research Foundation

​​Our Goal is to find treatments for the genetic disease SLC13A5 Deficiency.

TESS Research Foundation is a 501(c)(3) tax exempt public charity. Our mission is to help families affected by SLC13A5 Deficiency. SLC13A5 Deficiency (aka Citrate Transporter Disorder) is a newly discovered genetic cause of epilepsy, and as such, TESS Research Foundation is building a patient-centered network from the ground up. We are determined to diagnose, treat, and ultimately cure SLC13A5 Deficiency. We do this by funding cutting-edge research and connecting families, doctors, and researchers.

Yavi's Superhero Story

COVID Vaccines and Gene Therapy

/
Authors: This statement was modified with permission from a statement…

What is it like to live with epilepsy? - Interview with Kathryn

/
  Hi Kathryn! Please tell us a little about yourself and…

A Day in the Life of a Family Living with SLC13A5 - Windisch Family

/
Nicole and Rich are the parents of Meredith (2-years-old), who…

Subscribe to Updates

Tax Information

TESS Research Foundation

A 501(c)(3) nonprofit corporation

Tax ID Number: 47-3108868

Treatments for Epilepsy and Symptoms of SLC13A5

Contact Information

Kimberly Nye
655 Oak Grove Ave #53
Menlo Park, CA 94026

(650) 521-2279

E-Mail Kim